4-154586438-T-C
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_021871.4(FGA):āc.991A>Gā(p.Thr331Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.269 in 1,613,298 control chromosomes in the GnomAD database, including 60,604 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_021871.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGA | NM_021871.4 | c.991A>G | p.Thr331Ala | missense_variant | 5/5 | ENST00000403106.8 | NP_068657.1 | |
FGA | NM_000508.5 | c.991A>G | p.Thr331Ala | missense_variant | 5/6 | NP_000499.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGA | ENST00000403106.8 | c.991A>G | p.Thr331Ala | missense_variant | 5/5 | 1 | NM_021871.4 | ENSP00000385981.3 | ||
FGA | ENST00000651975.2 | c.991A>G | p.Thr331Ala | missense_variant | 5/6 | ENSP00000498441.1 |
Frequencies
GnomAD3 genomes AF: 0.294 AC: 44526AN: 151580Hom.: 6806 Cov.: 31
GnomAD3 exomes AF: 0.286 AC: 71751AN: 251264Hom.: 10915 AF XY: 0.285 AC XY: 38679AN XY: 135786
GnomAD4 exome AF: 0.266 AC: 388747AN: 1461600Hom.: 53787 Cov.: 37 AF XY: 0.267 AC XY: 194139AN XY: 727100
GnomAD4 genome AF: 0.294 AC: 44567AN: 151698Hom.: 6817 Cov.: 31 AF XY: 0.295 AC XY: 21846AN XY: 74128
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 23, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | This variant is associated with the following publications: (PMID: 32853977, 26139837, 18057060, 24821635, 10318664, 17433418, 19652888, 23894515, 19143925, 22353194, 10910940) - |
Congenital afibrinogenemia Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Familial visceral amyloidosis, Ostertag type Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Venous thromboembolism, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Mar 01, 2006 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at